Quin makes valid points but "guaranteed potency and purity" applies to compounded products from good pharmacies too. I've tested vials from three different 503B facilities and all came back between 97-103% potency via Janoshik. That's within the same USP specifications as branded products.

The real value proposition of brand is the delivery device (prefilled pen is undeniably more convenient) and the clinical trial data backing specific dose titration schedules.

Bottom line for anyone reading: if your insurance covers brand and you can get it for $25/month, do that. If you're paying out of pocket and looking at $1,200+/month vs $130-200/month, compounded from a reputable 503B facility is a legitimate option that millions of people are using safely.

The "right" choice depends entirely on your financial situation and risk tolerance. 💰

Has anyone looked into the Novo Nordisk patient assistance programs? I applied for one but got denied because my income was "too high" at $55k/year. Apparently their threshold is pretty low. Feels like another dead end.

Yeah, the PAP income thresholds are frustratingly low — typically 400% of federal poverty level or below. For a single person that's about $60,840 in 2026. If you're even slightly above that, you're out of luck. The cost savings cards are better but only work with commercial insurance, not Medicare/Medicaid.

The system is broken. That's why compounding exists. 🤷‍♀️